Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)

The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity for research projects that utilize existing human datasets addressing heart, lung, and blood diseases and sleep disorders. This R21 exploratory/developmental research grant (Funding Opportunity Announcement PAR-23-036) emphasizes secondary data analysis rather than the collection of new data, aiming to stimulate innovative scientific inquiries that can have significant impacts in biomedical research. Eligible applicants include a wide range of institutions, such as educational institutions, non-profits, and local governments. The funding available is projected at $2,187,000 per year over three fiscal years, with application budgets capped at $75,000 direct costs annually. The project duration cannot exceed two years. The grant application deadlines are set for February 28, 2023, and October 28, 2023, with a strict compliance requirement for application submissions. Notably, the FOA encourages collaborations with those holding access to various datasets, including the NHLBI BioData Catalyst, which offers a powerful cloud-based platform for data access and analysis. The initiative reflects the NIH's commitment to enhancing research efficiency through the strategic use of existing datasets.